Doug Wilson
Chief Tech/Sci/R&D Officer at Ferghana Partners Group
Profile
Douglas John Wilson is currently the Director at Vaxxit SRL, Mainz Consulting Ltd., and the Chief Medical Officer at Ferghana Partners Group.
He previously served as Chairman at SeaDragon Ltd.
from 2012 to 2015, Chairman at Adherium (NZ) Ltd., Non-Executive Chairman at Adherium Ltd., and Non-Independent Executive Director at Neuren Pharmaceuticals Ltd.
from 2011 to 2012.
He also served as Non-Executive Director at PYC Therapeutics Ltd.
from 2007 to 2016 and as Independent Non-Executive Director at Photonz Corp.
Ltd.
from 2011 to 2013.
Additionally, he is currently serving as an Independent Non-Executive Director at AFT Pharmaceuticals Ltd.
since 2012.
He previously worked as Senior Vice President-Medical & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He holds a doctorate degree from the University of London.
Doug Wilson active positions
| Companies | Position | Start |
|---|---|---|
Vaxxit SRL
 Vaxxit SRL BiotechnologyHealth Technology Vaxxit SRL develops a live recombinant vaccine for the treatment of oral herpes (HSV-1) and genital herpes (HSV-2). The company was founded by Giovanni Cozzone and is headquartered in Rome, Italy. | Director/Board Member | - |
| Mainz Consulting Ltd. | Director/Board Member | - |
Ferghana Partners Group
 Ferghana Partners Group Investment ManagersFinance Ferghana Partners Group provides healthcare corporate finance advisory services. | Chief Tech/Sci/R&D Officer | - |
Former positions of Doug Wilson
| Companies | Position | End |
|---|---|---|
| AFT PHARMACEUTICALS LIMITED | Director/Board Member | 2022-08-04 |
| PYC THERAPEUTICS LIMITED | Chairman | 2015-10-07 |
| SEADRAGON LIMITED | Chairman | 2015-05-03 |
| ADHERIUM LIMITED | Chairman | 2016-08-31 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Chief Tech/Sci/R&D Officer | - |
Training of Doug Wilson
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| PYC THERAPEUTICS LIMITED | Health Technology |
| AFT PHARMACEUTICALS LIMITED | Health Technology |
| ADHERIUM LIMITED | Health Technology |
| Private companies | 7 |
|---|---|
Ferghana Partners Group
Ferghana Partners Group Investment ManagersFinance Ferghana Partners Group provides healthcare corporate finance advisory services. | Finance |
SeaDragon Ltd.
 SeaDragon Ltd. Food: Specialty/CandyConsumer Non-Durables SeaDragon Ltd. engages in the manufacture of refined fish oils. It targets the production of Omega-3 bioactive compounds from three species: Tuna, Hoki, and marine-farmed Salmon. The company was founded on July 31, 1986 and is headquartered in Nelson, New Zealand. | Consumer Non-Durables |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Adherium (NZ) Ltd.
 Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Technology Services |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Health Technology |
Vaxxit SRL
Vaxxit SRL BiotechnologyHealth Technology Vaxxit SRL develops a live recombinant vaccine for the treatment of oral herpes (HSV-1) and genital herpes (HSV-2). The company was founded by Giovanni Cozzone and is headquartered in Rome, Italy. | Health Technology |
| Mainz Consulting Ltd. |
- Stock Market
- Insiders
- Doug Wilson
